These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6176506

  • 1. [In vitro measurement of fibrinolysis by urokinase].
    Senf L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
    [Abstract] [Full Text] [Related]

  • 2. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
    Lipinski B, Gurewich V, Hyde E.
    Thromb Diath Haemorrh; 1975 Sep 30; 34(1):351. PubMed ID: 1188799
    [No Abstract] [Full Text] [Related]

  • 3. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H, Takada Y, Takada A.
    Nihon Seirigaku Zasshi; 1977 Sep 30; 39(5):112-4. PubMed ID: 72149
    [No Abstract] [Full Text] [Related]

  • 4. Factor XIII cross-linking and the rate of fibrinolysis induced by streptokinase and urokinase.
    Rampling MW.
    Thromb Res; 1978 Feb 30; 12(2):287-95. PubMed ID: 635844
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 6. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S, Astrup T.
    Thromb Diath Haemorrh; 1974 Dec 31; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract] [Full Text] [Related]

  • 7. Dissolution of thrombi by tissue plasminogen activator, urokinase and streptokinase in an artificial circulating system.
    Mattsson C, Nyberg-Arrhenius V, Wallén P.
    Thromb Res; 1981 Mar 15; 21(6):535-45. PubMed ID: 7022741
    [No Abstract] [Full Text] [Related]

  • 8. Fibrinogen-fibrin related antigen pattern in human blood. Incomplete lysis of whole blood clots by urokinase.
    Jacobsen CD, Fry GL, Wu KK, Southers NJ.
    Thromb Res; 1975 Apr 15; 6(4):327-36. PubMed ID: 1079637
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on coagulation and fibrinolysis. III. Urokinase activated fibrinolysodynamicogram].
    Hu YM, Xue H, Wang KQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Jun 15; 4(3):133-6. PubMed ID: 6215134
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
    Roszkowska-Jakimiec W, Jurkowski J, Ostrowska H, Worowski K.
    Rocz Akad Med Bialymst (1989); 1982 Jun 15; 33-34():53-66. PubMed ID: 2979011
    [Abstract] [Full Text] [Related]

  • 11. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
    Thorsen S.
    Dan Med Bull; 1977 Oct 15; 24(5):189-206. PubMed ID: 908205
    [No Abstract] [Full Text] [Related]

  • 12. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits.
    Hisano S, Sueishi K, Ishii Y, Tanaka K.
    Thromb Haemost; 1979 Jun 30; 41(4):796-803. PubMed ID: 483251
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Low molecular weight heparin and high and low molecular weight urokinase in fibrinolysis in vivo].
    Badimón L, Villaverde CA, Vidal M, Valdecasas FG.
    Arch Farmacol Toxicol; 1979 Dec 30; 5(3):262-4. PubMed ID: 397803
    [No Abstract] [Full Text] [Related]

  • 15. Leukocyte-plasma interaction in fibrinolysis. A new dimension in the action of urokinase.
    Moroz LA, Sniderman AD, Marpole DG.
    N Engl J Med; 1979 Nov 15; 301(20):1100-4. PubMed ID: 158709
    [No Abstract] [Full Text] [Related]

  • 16. [Heparin and urokinase interactions in the fibrinolytic system].
    Villaverde CA, Badimón L, Badimón JJ, Valdecasas FG.
    Arch Farmacol Toxicol; 1979 Dec 15; 5(3):268-9. PubMed ID: 397804
    [No Abstract] [Full Text] [Related]

  • 17. [In vitro studies and model calculations on the kinetics of fibrinolysis with streptokinase].
    Senf L.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Dec 15; 106(5-6):899-907. PubMed ID: 94884
    [Abstract] [Full Text] [Related]

  • 18. The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards.
    Brommer EJ.
    Thromb Res; 1984 Apr 15; 34(2):109-15. PubMed ID: 6539513
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacology of fibrinolytics].
    Klöcking HP.
    Z Gesamte Inn Med; 1979 Jan 01; 34(1):22-8. PubMed ID: 373275
    [Abstract] [Full Text] [Related]

  • 20. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
    Singh K, Vézina C.
    J Med; 1974 Jan 01; 5(6):297-302. PubMed ID: 4528600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.